Industry
View all stories with this category.
-
BusinessChina makes slow progress on safety
Government policy drive continues, as self-regulation also grows
-
BusinessUS finalises guidance on biosimilars
Regulator clarifies requirements for allowing substitution between products
-
BusinessIndustry criticises proposed US asbestos ban
Outright ban would compromise chlorine supply and public health, claims trade body
-
OpinionIs Bayer regretting its Monsanto takeover?
Large damages in Roundup litigation have got investors questioning the move
-
BusinessJury awards $2bn damages in US glyphosate trial
Bayer vows to appeal third defeat over Monsanto’s Roundup weedkiller, while experts suggest damages will likely be reduced
-
BusinessFighting fake medicines
RxAll’s handheld scanner assesses drug quality in real time via a smartphone
-
OpinionIt's complicated
In a complex world, binary answers are often requested but rarely sufficient
-
BusinessEmerging from the US opioid crisis
With litigation against suppliers in full swing, how does the US counter its addiction to powerful painkillers?
-
BusinessAt least six dead in explosions in US and Russia
Blasts at silicones and fertiliser plants each leave three confirmed dead
-
SponsoredHow biologics have changed the rules for pharma
The impact of the latest generation of drugs for the healthcare industry